The top documents tagged [fda regulated products]

FDA Form 483 (Inspectional Observations) - Top Violations 2013
Health & Medicine FDA Form 483 (Inspectional Observations) - Top Violations 2013

304 views

FDA Compliance Actions Against IRBs and Clinical Investigators Paul W. Goebel, Jr., CIP Vice President pgoebel@irbinfo.com Chesapeake Research Review,
Documents FDA Compliance Actions Against IRBs and Clinical Investigators Paul W. Goebel, Jr., CIP Vice President [email protected] Chesapeake Research Review,

220 views

1 The U.S. Food and Drug Administration: FDA in Latin America: Overview, Goals, Objectives, Opportunities Michael Rogers, M.S. Director, Latin America
Documents 1 The U.S. Food and Drug Administration: FDA in Latin America: Overview, Goals, Objectives, Opportunities Michael Rogers, M.S. Director, Latin America

214 views

The Draft Guidance Word Version.doc
Business The Draft Guidance Word Version.doc

1.281 views

USFDA GUIDLINES
Education USFDA GUIDLINES

1.495 views

Presentation for Alabama Hospital Association. Objectives 1.To familiarize Hospital Association Personnel with federal criminal violations that they may
Documents Presentation for Alabama Hospital Association. Objectives 1.To familiarize Hospital Association Personnel with federal criminal violations that they may

217 views

FDA Regulated Products: Understanding & Combating Counterfeiters Presented by: Owen J. McKeon Director Gibbons P.C. omckeon@gibbonslaw.com
Documents FDA Regulated Products: Understanding & Combating Counterfeiters Presented by: Owen J. McKeon Director Gibbons P.C. [email protected]

218 views

History of the Montreal Protocol and 21 CFR 2.125 Robert J. Meyer, MD Director, ODE II / CDER
Documents History of the Montreal Protocol and 21 CFR 2.125 Robert J. Meyer, MD Director, ODE II / CDER

216 views

Upcoming IRB Improvements for AAHRPP and Best Practice 4 th Friday Research Coordinator Lunch & Learn 8/28/09 Monika Markowitz, PhD, MA, RN, MSN Director,
Documents Upcoming IRB Improvements for AAHRPP and Best Practice 4 th Friday Research Coordinator Lunch & Learn 8/28/09 Monika Markowitz, PhD, MA, RN, MSN Director,

219 views

History of the Montreal Protocol, FDA regulation of CFCs and Background to Meeting Robert J. Meyer, MD Director, ODE II / CDER
Documents History of the Montreal Protocol, FDA regulation of CFCs and Background to Meeting Robert J. Meyer, MD Director, ODE II / CDER

225 views

UNCLASSIFIED Slide 1 of 37 FDA-Regulated Mobile Medical Apps LTC David Shoemaker, PhD, RAC Deputy Director, Division of Regulated Activities and Compliance
Documents UNCLASSIFIED Slide 1 of 37 FDA-Regulated Mobile Medical Apps LTC David Shoemaker, PhD, RAC Deputy Director, Division of Regulated Activities and Compliance

217 views

FDA Considerations For Regulation Of Nanomaterial Containing Products Nakissa Sadrieh, Ph.D. Office of Pharmaceutical Science, CDER, FDA
Documents FDA Considerations For Regulation Of Nanomaterial Containing Products Nakissa Sadrieh, Ph.D. Office of Pharmaceutical Science, CDER, FDA

221 views